Financial Statements Directors’ Report for the year ended 31 December 2023 The Directors have pleasure in submitting their report and the audited financial statements of the Group and of the Company for the financial year ended 31 December 2023. PRINCIPAL ACTIVITIES The principal activities of the Company are those relating to investment holding and the provision of consultancy and support services, whilst the principal activities of the subsidiaries are as stated in note 41 to the financial statements. There has been no significant change in the nature of these activities during the financial year. SUBSIDIARIES The details of the Company’s subsidiaries are disclosed in note 41 to the financial statements. RESULTS Group RM’000 Company RM’000 Profit for the year attributable to: Owners of the Company 2,951,874 1,370,647 Non-controlling interests 439,081 – 3,390,955 1,370,647 RESERVES AND PROVISIONS Except as disclosed in the financial statements, there were no material transfers to or from reserves and provisions during the financial year under review. DIVIDENDS Since the end of the previous financial year, the Company paid a first and final single tier cash dividend of 7.0 sen per ordinary share amounting to RM616,489,000 for the financial year ended 31 December 2022 on 28 April 2023, a special cash dividend of 9.6 sen per ordinary share amounting to RM845,472,000 for the financial year ended 31 December 2023 on 30 June 2023 and an interim cash dividend of 3.5 sen per ordinary share amounting to RM308,244,000 for the financial year ended 31 December 2023 on 27 October 2023. The Board of Directors has declared that a final cash dividend of 5.5 sen per ordinary share for the financial year ended 31 December 2023 to be paid on 26 April 2024 to shareholders whose names appear in the Record of Depositors of Bursa Malaysia Depository Sdn. Bhd. and The Central Depository (Pte) Limited (“CDP”) at the close of business on 27 March 2024. The Company shall apply the RM:SGD noon middle rate as disclosed in the Bank Negara Malaysia’s website on 27 March 2024 as the basis for computing the dividend quantum to be paid in SGD to the Singapore investors whose Company’s shares are traded on SGX-ST. DIRECTORS OF THE COMPANY Directors who served during the financial year until the date of this report are: Tan Sri Mohammed Azlan Bin Hashim Takeshi Akutsu Tomo Nagahiro Appointed on 3 February 2023 Lim Tsin-Lin Appointed on 16 February 2023 Mehmet Ali Aydinlar Mohd Shahazwan Bin Mohd Harris Appointed on 29 March 2023 Jill Margaret Watts Dato' Sri Muthanna Bin Abdullah Ong Ai Lin Satoshi Tanaka Mok Jia Mei (Alternate Director to Lim Tsin-Lin) Appointed on 16 February 2023 Takeshi Saito Resigned on 27 January 2023 Dr. Farid Bin Mohamed Sani Resigned on 10 February 2023 Dr. Kelvin Loh Chi-Keon Resigned on 22 February 2023 Tunku Alizakri Bin Raja Muhammad Alias Resigned on 16 March 2023 Mok Jia Mei (Alternate Director to Dr. Farid Bin Mohamed Sani) Resigned on 10 February 2023 Tomo Nagahiro (Alternate Director to Takeshi Akutsu) Resigned on 27 January 2023 IHH Healthcare Berhad 126
RkJQdWJsaXNoZXIy NDgzMzc=